EcoDrugPlus

Tumor Protein P53

Ensembl ID : ENSSPAG00000016632
Gene Symbol: TP53
2 Cross references
232 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSSPAG00000004856
Gene Symbol: TYR
4 Cross references
198 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSSPAG00000020644
Gene Symbol: TYR
3 Cross references
202 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSSPAG00000001549
Gene Symbol: TH
3 Cross references
187 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSSPAG00000000577
Gene Symbol: TYK2
3 Cross references
195 Possible Orthologues:

Tyrosine-Protein Kinase Jak2-Like

Ensembl ID : ENSSPAG00000013316
Gene Symbol: LOC103366422
3 Cross references
194 Possible Orthologues:

Tyrosine-Protein Kinase Fyna

Ensembl ID : ENSSPAG00000020207
Gene Symbol: LOC103353777
3 Cross references
191 Possible Orthologues:

Tyrosine-Protein Kinase Receptor Tie-1-Like

Ensembl ID : ENSSPAG00000015840
Gene Symbol: LOC103370719
3 Cross references
205 Possible Orthologues:

Tyrosine-Protein Kinase Yes

Ensembl ID : ENSSPAG00000000595
Gene Symbol: LOC103361570
3 Cross references
206 Possible Orthologues:

Uncharacterized Loc103358541

Ensembl ID : ENSSPAG00000013286
Gene Symbol: LOC103358541
2 Cross references
196 Possible Orthologues:

Uncharacterized Loc103360164

Ensembl ID : ENSSPAG00000016276
Gene Symbol: LOC103360164
2 Cross references
212 Possible Orthologues:

Utrophin

Ensembl ID : ENSSPAG00000004442
Gene Symbol: UTRN
2 Cross references
270 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).